Novateor Research Laboratories Ltd
₹ 37.8
11.18%
07 Feb
- close price
About
Incorporated in 2011, Novateor Research Laboratories Ltd develops personal care products[1]
Key Points
- Market Cap ₹ 18.3 Cr.
- Current Price ₹ 37.8
- High / Low ₹ 56.8 / 30.6
- Stock P/E 365
- Book Value ₹ 20.0
- Dividend Yield 0.00 %
- ROCE 0.86 %
- ROE 0.36 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has a low return on equity of 1.27% over last 3 years.
- Company has high debtors of 338 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: FMCG Industry: Personal Care - Indian
Loading peers table ...
Half Yearly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.03 | 0.02 | 0.10 | 0.14 | 0.09 | 0.41 | 0.39 | 0.19 | 0.74 | 1.26 | 1.21 | 1.64 | |
0.00 | 0.03 | 0.02 | 0.11 | 0.08 | 0.04 | 0.13 | 0.53 | 0.52 | 0.92 | 1.60 | 1.54 | 1.90 | |
Operating Profit | 0.00 | 0.00 | 0.00 | -0.01 | 0.06 | 0.05 | 0.28 | -0.14 | -0.33 | -0.18 | -0.34 | -0.33 | -0.26 |
OPM % | 0.00% | 0.00% | -10.00% | 42.86% | 55.56% | 68.29% | -35.90% | -173.68% | -24.32% | -26.98% | -27.27% | -15.85% | |
0.00 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 | 0.11 | 0.27 | 0.44 | 0.01 | 0.49 | 0.49 | 0.48 | |
Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.02 | 0.03 | 0.03 |
Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.07 | 0.10 | 0.10 | 0.10 | 0.09 | 0.09 | 0.08 | 0.10 |
Profit before tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.29 | 0.02 | 0.01 | -0.26 | 0.04 | 0.05 | 0.09 |
Tax % | 24.14% | 150.00% | 0.00% | -11.54% | 0.00% | 40.00% | |||||||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 | -0.01 | 0.01 | -0.23 | 0.04 | 0.03 | 0.05 | |
EPS in Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.74 | -0.02 | 0.02 | -0.48 | 0.08 | 0.06 | 0.10 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | 45% |
5 Years: | 24% |
3 Years: | 85% |
TTM: | 105% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | -33% |
3 Years: | 44% |
TTM: | 25% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | 31% |
3 Years: | 48% |
1 Year: | -11% |
Return on Equity | |
---|---|
10 Years: | 1% |
5 Years: | 1% |
3 Years: | 1% |
Last Year: | 0% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 0.04 | 0.05 | 0.05 | 0.05 | 0.05 | 0.05 | 2.96 | 4.83 | 4.83 | 4.83 | 4.83 | 4.83 | 4.83 |
Reserves | 0.71 | 0.88 | 0.88 | 0.88 | 0.88 | 0.88 | 1.11 | 3.73 | 3.74 | 3.01 | 3.04 | 3.93 | 4.82 |
0.00 | 0.59 | 0.75 | 0.76 | 0.87 | 0.82 | 0.01 | 0.00 | 0.24 | 0.24 | 0.84 | 1.11 | 0.73 | |
0.03 | 0.00 | 0.11 | 0.15 | 0.10 | 0.09 | 0.24 | 0.23 | 0.17 | 0.06 | 0.24 | 0.59 | 0.75 | |
Total Liabilities | 0.78 | 1.52 | 1.79 | 1.84 | 1.90 | 1.84 | 4.32 | 8.79 | 8.98 | 8.14 | 8.95 | 10.46 | 11.13 |
0.76 | 1.41 | 1.59 | 1.64 | 1.66 | 1.59 | 3.55 | 3.45 | 3.36 | 1.94 | 1.78 | 2.43 | 3.05 | |
CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.43 | 0.44 | 0.00 |
Investments | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
0.02 | 0.10 | 0.19 | 0.19 | 0.23 | 0.24 | 0.76 | 5.33 | 5.61 | 6.19 | 6.73 | 7.58 | 8.07 | |
Total Assets | 0.78 | 1.52 | 1.79 | 1.84 | 1.90 | 1.84 | 4.32 | 8.79 | 8.98 | 8.14 | 8.95 | 10.46 | 11.13 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.05 | -0.07 | -3.42 | -0.27 | -0.97 | -0.97 | -0.98 | |
0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -1.96 | -0.10 | -0.09 | 0.91 | 0.13 | -0.25 | |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.03 | 2.03 | 4.18 | 0.32 | -0.13 | 0.58 | 1.10 | |
Net Cash Flow | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.02 | 0.00 | 0.67 | -0.04 | -0.18 | -0.26 | -0.13 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 365.00 | 365.00 | 219.00 | 182.50 | 243.33 | 133.54 | 233.97 | 384.21 | 212.09 | 202.78 | 337.85 | |
Inventory Days | 2,190.00 | 4,380.00 | 438.00 | 1,460.00 | 2,737.50 | 6,448.33 | 700.80 | 851.67 | 344.34 | 215.16 | 268.95 | |
Days Payable | 365.00 | 1,460.00 | 292.00 | 730.00 | 1,095.00 | 1,460.00 | 14.60 | 104.29 | 20.66 | 61.47 | 207.47 | |
Cash Conversion Cycle | 2,190.00 | 3,285.00 | 365.00 | 912.50 | 1,885.83 | 5,121.87 | 920.17 | 1,131.59 | 535.77 | 356.46 | 399.32 | |
Working Capital Days | 973.33 | 1,277.50 | 109.50 | 365.00 | 527.22 | 462.93 | 4,117.95 | 9,067.37 | 2,747.36 | 1,752.58 | 2,072.36 | |
ROCE % | 0.00% | 0.00% | 0.57% | 0.56% | 9.95% | 0.47% | 0.12% | 2.49% | 0.71% | 0.86% |
Documents
Announcements
-
Launch Of New Product_Smiloshine Sensitive Nitraguard Toothpaste
6 Feb - Launch of SmiloShine Sensitive Nitraguard Toothpaste on 15th February.
-
Launch Of New Product_Smiloshine Chocojoy Toothpaste
6 Feb - Launch of SmiloShine ChocoJoy Toothpaste on 14th February 2025.
-
Board Meeting Outcome for Acceptance Of Resignation Of Mrs. Tejal Mehta As Whole Time Director Of The Company
12 Jan - Resignation of Whole Time Director Tejal Mehta.
-
Announcement under Regulation 30 (LODR)-Resignation of Director
12 Jan - Resignation of Whole Time Director Tejal Mehta.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
4 Jan - Confirmation certificate under SEBI regulations for Q4 2024.
Business Overview:[1]
Company manufactures Teeth Whitening products which are sold under brand name SmiloShine. It manufactures ~3 variants of Strips, Toothpaste and tongue cleaner which are approved by FDCA. Company intends to expand its business in cosmetics and healthcare products. Company’s customer base consists of Dentists and Cosmetic Parlors